Swiss pharmaceutical group Roche https://www.reuters.com/markets/companies/ROG.S” target=”_blank” rel=”noopener”>(ROG.S) said on Monday it had entered into a partnership with U.S. biopharmaceutical company Alnylam to co-develop and co-commercialise zilebesiran,…
Read More
About The Author
